34.03
price down icon2.72%   -0.95
after-market Handel nachbörslich: 34.69 0.66 +1.94%
loading

Dianthus Therapeutics Inc Aktie (DNTH) Neueste Nachrichten

pulisher
01:30 AM

Dianthus Therapeutics Reports Positive Phase 2 Results - TipRanks

01:30 AM
pulisher
01:15 AM

Dianthus Therapeutics, Inc. Updates Corporate Presentation - TradingView

01:15 AM
pulisher
09:36 AM

Will Dianthus Therapeutics Inc. stock see PE expansionWeekly Market Outlook & Daily Profit Focused Screening - newser.com

09:36 AM
pulisher
08:58 AM

How Dianthus Therapeutics Inc. stock reacts to global recession fearsMarket Growth Report & Smart Allocation Stock Tips - newser.com

08:58 AM
pulisher
07:15 AM

Is Dianthus Therapeutics Inc. (87E) stock a fit for income portfoliosNew Guidance & Breakout Confirmation Trade Signals - newser.com

07:15 AM
pulisher
05:52 AM

Trend analysis for Dianthus Therapeutics Inc. this weekJuly 2025 Sentiment & Scalable Portfolio Growth Ideas - newser.com

05:52 AM
pulisher
05:45 AM

Smart tools for monitoring Dianthus Therapeutics Inc.’s price actionRate Hike & Growth Oriented Trading Recommendations - newser.com

05:45 AM
pulisher
04:58 AM

What recovery options are there for Dianthus Therapeutics Inc.July 2025 Final Week & Free Community Consensus Stock Picks - newser.com

04:58 AM
pulisher
04:32 AM

Why Dianthus Therapeutics Inc. stock remains resilientDay Trade & Weekly Market Pulse Updates - newser.com

04:32 AM
pulisher
03:51 AM

Will Dianthus Therapeutics Inc. (87E) stock hit Wall Street targetsJuly 2025 Sentiment & Entry Point Confirmation Alerts - newser.com

03:51 AM
pulisher
03:46 AM

How to escape a deep drawdown in Dianthus Therapeutics Inc.Gap Up & Growth Focused Stock Reports - newser.com

03:46 AM
pulisher
01:32 AM

Will Dianthus Therapeutics Inc. (87E) stock outperform value peersJuly 2025 Pullbacks & Daily Market Momentum Tracking - newser.com

01:32 AM
pulisher
12:51 PM

Using Python tools to backtest Dianthus Therapeutics Inc. strategiesJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - newser.com

12:51 PM
pulisher
Nov 02, 2025

Will Dianthus Therapeutics Inc. (87E) stock gain from green policiesMarket Risk Summary & Expert Verified Movement Alerts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Long term hold vs stop loss in Dianthus Therapeutics Inc.2025 Momentum Check & Fast Moving Stock Watchlists - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Dianthus Therapeutics Inc. stock chart pattern explainedMarket Risk Report & Community Trade Idea Sharing Platform - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Using Bollinger Bands to evaluate Dianthus Therapeutics Inc.July 2025 Review & AI Optimized Trade Strategies - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Can Dianthus Therapeutics Inc. stock hit analyst price targetsWeekly Gains Report & Verified Momentum Stock Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Dianthus Therapeutics, Inc. (DNTH) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Oct 31, 2025
pulisher
Oct 31, 2025

Using economic indicators to assess Dianthus Therapeutics Inc. potentialWeekly Gains Summary & Risk Managed Trade Strategies - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Dianthus Therapeutics (DNTH) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

What to expect from Dianthus Therapeutics Inc. in the next 30 daysJuly 2025 WrapUp & Daily Entry Point Trade Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How to monitor Dianthus Therapeutics Inc. with trend dashboardsWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Dianthus Therapeutics, Inc. (DNTH) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025
pulisher
Oct 30, 2025

Dianthus Therapeutics, Inc. (DNTH) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Oct 30, 2025
pulisher
Oct 30, 2025

How New Phase 2 MaGic Data on Claseprubart Has Changed the Investment Story at Dianthus Therapeutics (DNTH) - Sahm

Oct 30, 2025
pulisher
Oct 29, 2025

Dianthus Therapeutics Highlights New Claseprubart Data Presented During 2025 AANEM Annual Meeting - The Manila Times

Oct 29, 2025
pulisher
Oct 29, 2025

Dianthus Therapeutics Reports Positive Phase 2 MaGic Trial Data for Claseprubart in Generalized Myasthenia Gravis and Plans Phase 3 Trial Initiation in 2026 - Quiver Quantitative

Oct 29, 2025
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):